Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-((2-dimethylaminoethyl)-3-thenylamino)pyridine
1. Tenfidil
2. Thefanil
3. Thenfadil
4. 91-79-2
5. Dethylandiamine
6. Tenildiamina
7. Thenyldiaminum
8. Nci-c60640
9. Win-2848
10. 2-((2-dimethylaminoethyl)-3-thenylamino)pyridine
11. Dtxsid0021335
12. 2-((2-(dimethylamino)ethyl)-3-thenylamino)pyridine
13. N-(2-dimethylaminoethyl)-n-2-pyridyl-3-thenylamine
14. 1,2-ethanediamine, N,n-dimethyl-n'-2-pyridinyl-n'-(3-thienylmethyl)-
15. E4u52363je
16. Pyridine, 2-((2-(dimethylamino)ethyl)-3-thenylamino)-
17. Dtxcid601335
18. N-(alpha-pyridyl)-n-(beta-thenyl)-n',n'-dimethylethylenediamine
19. N,n-dimethyl-n'-(alpha-pyridyl)-n'-(3-methylthienyl)ethylenediamine
20. N,n-dimethyl-n'-2-pyridinyl-n'-(3-thienylmethyl)-1,2-ethanediamine
21. 2-[(2-dimethylaminoethyl)-3-thenylamino]pyridine
22. Pyridine, 2-[[2-(dimethylamino)ethyl]-3-thenylamino]-
23. Refchem:189171
24. 202-098-2
25. Thenyldiamine (pharmaceutical)
26. N,n-dimethyl-n'-pyridin-2-yl-n'-(thiophen-3-ylmethyl)ethane-1,2-diamine
27. Thenyldiamine [inn:ban]
28. Tenildiamina [inn-spanish]
29. Thenyldiaminum [inn-latin]
30. Hsdb 5190
31. Einecs 202-098-2
32. Brn 0221267
33. Dethlandiamine
34. Unii-e4u52363je
35. Thenyldiamine [mi]
36. Thenyldiamine [inn]
37. Thenyldiamine [hsdb]
38. Schembl28948
39. 4-22-00-03953 (beilstein Handbook Reference)
40. Win 2848
41. Thenyldiamine [who-dd]
42. Chembl2107485
43. Chebi:186232
44. Tox21_113737
45. N,n-dimethyl-n'-pyridin-2-yl-n'-(3-thienylmethyl)ethane-1,2-diamine
46. N-[2-(dimethylamino)ethyl]-n-[(thiophen-3-yl)methyl]pyridin-2-amine
47. Cas-91-79-2
48. Ncgc00253602-01
49. Ns00005291
50. En300-18553886
51. Q7781412
52. 1,2-ethanediamine,n1,n1-dimethyl-n2-2-pyridinyl-n2-(3-thienylmethyl)-
53. N-(.alpha.-pyridyl)-n-(.beta.-thenyl)-n',n'-dimethylethylenediamine
| Molecular Weight | 261.39 g/mol |
|---|---|
| Molecular Formula | C14H19N3S |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 47.6 |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 235 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Nasal Decongestants; Histamine H1 Antagonists
National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)
THESE INCLUDE SOME OF THE MOST SPECIFIC AND ACTIVE H1 ANTAGONISTS. ALTHOUGH THEIR CENTRAL EFFECTS ARE RELATIVELY FEEBLE AND OF NO THERAPEUTIC VALUE, SOMNOLENCE OCCURS. /ETHYLENEDIAMINES/
Gilman, A. G., L. S. Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., Inc. 1980., p. 627
ANTIHISTAMINIC AGENT (AS HYDROCHLORIDE)
SRI
ANTIHISTAMINIC AGENT; PRC: FORMERLY USED AS A SEDATIVE /HYDROCHLORIDE/
The Merck Index. 9th ed. Rahway, New Jersey: Merck & Co., Inc., 1976., p. 1195
ABOUT THIS PAGE
85
PharmaCompass offers a list of Thenyldiamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Thenyldiamine manufacturer or Thenyldiamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Thenyldiamine manufacturer or Thenyldiamine supplier.
A Thenyldiamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Thenyldiamine, including repackagers and relabelers. The FDA regulates Thenyldiamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Thenyldiamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Thenyldiamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Thenyldiamine supplier is an individual or a company that provides Thenyldiamine active pharmaceutical ingredient (API) or Thenyldiamine finished formulations upon request. The Thenyldiamine suppliers may include Thenyldiamine API manufacturers, exporters, distributors and traders.
click here to find a list of Thenyldiamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
Thenyldiamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Thenyldiamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Thenyldiamine GMP manufacturer or Thenyldiamine GMP API supplier for your needs.
A Thenyldiamine CoA (Certificate of Analysis) is a formal document that attests to Thenyldiamine's compliance with Thenyldiamine specifications and serves as a tool for batch-level quality control.
Thenyldiamine CoA mostly includes findings from lab analyses of a specific batch. For each Thenyldiamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Thenyldiamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Thenyldiamine EP), Thenyldiamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Thenyldiamine USP).
